RBesT (version 1.3-7)

AS: Ankylosing Spondylitis.

Description

Data set containing historical information for placebo for a phase II trial of ankylosing spondylitis patients. The primary efficacy endpoint was the percentage of patients with a 20 according to the Assessment of SpondyloArthritis international Society criteria for improvement (ASAS20) at week 6.

Usage

AS

Format

A data frame with 8 rows and 3 variables:

study

study

n

study size

r

number of events

References

Baeten D. et. al, The Lancet, 2013, (382), 9906, p 1705

Examples

# NOT RUN {
set.seed(34563)
map_AS <- gMAP(cbind(r, n-r) ~ 1 | study,
               family=binomial,
               data=AS,
               tau.dist="HalfNormal", tau.prior=1,
               beta.prior=2,
               ## ensure fast example runtime
               thin=1, chains=1)
# }